Reaction Details |
| Report a problem with these data |
Target | Aurora kinase A |
---|
Ligand | BDBM50340956 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_740044 (CHEMBL1763104) |
---|
IC50 | 6200±n/a nM |
---|
Citation | Zagotto, G; Redaelli, M; Pasquale, R; D'Avella, D; Cozza, G; Denaro, L; Pizzato, F; Mucignat-Caretta, C 8-Hydroxynaphthalene-1,4-dione derivative as novel compound for glioma treatment. Bioorg Med Chem Lett21:2079-82 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Aurora kinase A |
---|
Name: | Aurora kinase A |
Synonyms: | AIK | AIRK1 | ARK-1 | ARK1 | AURA | AURKA | AURKA_HUMAN | AYK1 | Aurora 2 | Aurora kinase A (AURA) | Aurora kinase A (AURKA) | Aurora kinase A (Aurora A) | Aurora kinase A (Aurora-2) | Aurora-related kinase 1 | Aurora/IPL1-related kinase 1 | BTAK | Breast tumor-amplified kinase | Breast-tumor-amplified kinase | IAK1 | STK15 | STK15 GN | STK6 | Serine/threonine kinase 15 | Serine/threonine-protein kinase 15 | Serine/threonine-protein kinase 6 | Serine/threonine-protein kinase aurora A | Serine/threonine-protein kinase aurora-A | Synonyms=AIK | aurora-2 | hARK1 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 45830.98 |
Organism: | Homo sapiens (Human) |
Description: | O14965 |
Residue: | 403 |
Sequence: | MDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCPSNSSQRIPLQ
AQKLVSSHKPVQNQKQKQLQATSVPHPVSRPLNNTQKSKQPLPSAPENNPEEELASKQKN
EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR
EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL
ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM
IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI
SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS
|
|
|
BDBM50340956 |
---|
n/a |
---|
Name | BDBM50340956 |
Synonyms: | 5,8-dihydroxy-2-(2,3,4-trihydroxyphenyl)naphthalene-1,4-dione | CHEMBL1762119 |
Type | Small organic molecule |
Emp. Form. | C16H10O7 |
Mol. Mass. | 314.2464 |
SMILES | Oc1ccc(C2=CC(=O)c3c(O)ccc(O)c3C2=O)c(O)c1O |t:5| |
Structure |
|